Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Flexor Tenolysis Treatment & Management

  • Author: Cato T Laurencin, MD, PhD; Chief Editor: Harris Gellman, MD  more...
 
Updated: Nov 02, 2015
 

Medical Therapy

Although steroid injections to augment tendon repair are notable in the literature,[14, 15, 16] they are not universal, and by the time tendon adhesions occur, there is no currently accepted medical therapy to treat the condition.[2]

Next

Surgical Therapy

Flexor tenolysis is a surgical procedure.

Previous
Next

Preoperative Details

Make sure patient meets all indications for surgery to proceed, including a rigorous examination of external anatomy to check for mature scarring and good passive range of motion.

Previous
Next

Intraoperative Details

Since the 1970s, flexor tenolysis has been popularly performed using local anesthesia alone.[17] Benefits for this include the fact that the surgeon may actively engage with the patient to ensure that the tendon is free from adhesions to glide in the tendon canal. Active participation from the patient also establishes whether the musculature for digit flexion is strong enough to power tendon contraction.

General anesthesia can still be considered for patient-specific factors, including inability to irritability, anxiety, or a complicated surgical plan owing to multiple affected tendons. Under circumstances of general anesthesia, active flexion can be ascertained by opening a surgical window proximal to the affected tendon as described by Whitaker et al.[14] Using this opened window, surgeons can pull on the tendons to simulate muscular contraction.

The surgery starts by exposing the full length of the flexor tendon through either a zigzag or midlateral incision. A zigzag incision, championed by Schneider, provides the best operative window to the flexor tendon and pulley system.[18, 19] The midlateral incision is believed to diminish the presence of scarring directly over the affected flexor tendon and puts the neural and vascular structures at less risk.[20]

After exposure, both flexor tendons (FDP and FDS) are raised from underlying structures, and all tendon adhesions are lysed. After adhesions are removed between the tendons and the sheath, it is usually recommended to remove adhesions between the FDP and FDS, with sacrifice of the FDS being necessary if free tendon gliding cannot be accomplished otherwise.[19]

During the process of removing adhesions, the participation of the patient can be critical, especially when trying to differentiate between scar tissue and the pulley system. Although adhesion removal using lasers has been described in rabbits, the practice has failed to gain a wide clinical following in the human population, and most surgeons still use traditional hand instruments modified for the procedure.[21] Preservation of the pulley system, especially the A2 and A4 pulleys, is vital for normal flexor tendon activity. Less commonly, the pulley structures are compromised and a pulley reconstruction may be indicated.[2, 19] Usually, this procedure continues and adhesions are removed until full active flexion can be achieved.

The final stage of the surgery is to assess whether the tendon is robust enough to progress through the rigorous physical therapy necessitated by this complex procedure. Both scarring and substantial tendon tissue loss (>30% width lost) can put the patient at risk, and in such situations it is generally recommended that the patient undergo a 2-stage tendon reconstruction.[11, 18, 19, 20, 22] Some physicians treat patients with steroids at this point in order to abrogate the formation of new adhesions during recovery, but as steroids have a well-described capability to limit the healing response, many abstain from their use altogether. Starting in the 1930s, physicians have described the use of various other natural or synthetic materials to prevent subsequent formation of tendon adhesions,[23, 24] but these techniques have failed to gain widespread acceptance as of yet.

Previous
Next

Postoperative Details

Physical therapy is absolutely necessary for healthy tendon function to return, and poorly controlled pain can hamper the recovery effort. To reduce postoperative pain, most physicians recommend oral analgesia, but every patient is different, and severe cases of pain may necessitate more extreme measures, including indwelling catheters capable of dispensing local anesthesia.[20]

When to start physical therapy in an issue up for debate. As immobilization is necessary for the tendon adhesions to form, some physicians recommend immediate hand exercises, while others recommend waiting for a period of days until the effects of the surgical approach (inflammation, scarring) have diminished.

The level and rigor of physical therapy should take the individual surgery of the patient into consideration. If upon surgical exposure of the flexor tendon, the surgeon notices significant impairment in the health and quality of the tendon, this important information should be relayed to the physical therapist, who may then appropriately modify a treatment plan. Protocols for patients with poor tendon quality are well documented and have shown improved results compared with a protocol for a healthier tendon.[25] A common protocol for patients with a healthy tendon is to undergo physical therapy 3-5 days per week at first and then slowly decrease the frequency of physical therapy over a period of weeks to months, with the goal of decreasing pain and increasing range of motion and strength.

Previous
Next

Follow-up

Patient compliance with physical therapy is mandatory for this procedure.

Previous
Next

Complications

Some studies have shown that as many as 20% of patients who undergo this procedure do not benefit from the operation, and 8% of patients experience frank tendon rupture, with some studies showing rates as high as 15%.[5, 25, 26]

Previous
Next

Outcome and Prognosis

As flexor tenolysis is a very individualized procedure, there are widely disparate reports of how much active flexor range of motion will increase. It has been reported that active range of motion increases for between 59% and 90% of all patients.[5]

Previous
Next

Future and Controversies

While this procedure has proven to be effective in the majority of cases, the complication rate is still very high, and much research is needed into protocols, surgical techniques, or materials that can restore active range of motion to patients.

One way to combat the formation of adhesions after flexor tenolysis would be to find a therapy that could decrease the immunological response to the surgery.[27, 28] As mentioned before, corticosteroids have been tried, but their limitations are too severe for widespread acceptance.

A crucial aspect of the surgery is to respect the pulley system for the flexor tendons. A safer way to reconstruct the pulley system using natural or synthetic materials could potentially improve the prognosis for this procedure.[29] While significant research has been performed on implantable, interpositional materials, human trials have, to date, been lacking in rigor. A potential candidate that has emerged would be to use the joint matrix protein derivative Seprafilm, which that has emerged as a useful therapeutic in the reduction of adhesions in surgery involving the gastrointestinal tract.[24] Further studies are warranted.

Previous
 
Contributor Information and Disclosures
Author

Cato T Laurencin, MD, PhD University Professor, Albert and Wilda Van Dusen Endowed Distinguished Professor of Orthopedic Surgery, and Professor of Chemical, Materials, and Biomolecular Engineering, University of Connecticut School of Medicine

Cato T Laurencin, MD, PhD is a member of the following medical societies: American Academy of Orthopaedic Surgeons

Disclosure: Nothing to disclose.

Coauthor(s)

Clarke Nelson University of Connecticut School of Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Thomas R Hunt III, MD Professor and Chairman, Joseph Barnhart Department of Orthopedic Surgery, Baylor College of Medicine

Thomas R Hunt III, MD is a member of the following medical societies: American Orthopaedic Association, American Orthopaedic Society for Sports Medicine, Southern Orthopaedic Association, AO Foundation, American Academy of Orthopaedic Surgeons, American Association for Hand Surgery, American Society for Surgery of the Hand, Mid-America Orthopaedic Association

Disclosure: Received royalty from Tornier for independent contractor; Received ownership interest from Tornier for none; Received royalty from Lippincott for independent contractor.

Chief Editor

Harris Gellman, MD Consulting Surgeon, Broward Hand Center; Voluntary Clinical Professor of Orthopedic Surgery and Plastic Surgery, Departments of Orthopedic Surgery and Surgery, University of Miami, Leonard M Miller School of Medicine, Clinical Professor, Surgery, Nova Southeastern School of Medicine

Harris Gellman, MD is a member of the following medical societies: American Academy of Medical Acupuncture, American Academy of Orthopaedic Surgeons, American Orthopaedic Association, American Society for Surgery of the Hand, Arkansas Medical Society

Disclosure: Nothing to disclose.

Additional Contributors

Michael S Clarke, MD Clinical Associate Professor, Department of Orthopedic Surgery, University of Missouri-Columbia School of Medicine

Michael S Clarke, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, Arthroscopy Association of North America, American Academy of Pediatrics, American Association for Hand Surgery, American College of Surgeons, American Medical Association, Clinical Orthopaedic Society, Mid-Central States Orthopaedic Society, Missouri State Medical Association

Disclosure: Nothing to disclose.

Acknowledgements

W Jay Gorum II, MD Consulting Surgeon, Gorum Orthopedics and Associates

W Jay Gorum II, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons

Disclosure: Nothing to disclose.

References
  1. Derby BM, Wilhelmi BJ, Zook EG, Neumeister MW. Flexor tendon reconstruction. Clin Plast Surg. 2011 Oct. 38(4):607-19. [Medline].

  2. Azari KK, Meals RA. Flexor tenolysis. Hand Clin. 2005 May. 21(2):211-7. [Medline].

  3. Eggli S, Dietsche A, Eggli S, Vögelin E. Tenolysis after combined digital injuries in zone II. Ann Plast Surg. 2005 Sep. 55(3):266-71. [Medline].

  4. Wong JK, Lui YH, Kapacee Z, Kadler KE, Ferguson MW, McGrouther DA. The cellular biology of flexor tendon adhesion formation: an old problem in a new paradigm. Am J Pathol. 2009 Nov. 175(5):1938-51. [Medline].

  5. Dy CJ, Daluiski A, Do HT, Hernandez-Soria A, Marx R, Lyman S. The epidemiology of reoperation after flexor tendon repair. J Hand Surg Am. 2012 May. 37(5):919-24. [Medline].

  6. Caulfield RH, Maleki-Tabrizi A, Patel H, Coldham F, Mee S, Nanchahal J. Comparison of zones 1 to 4 flexor tendon repairs using absorbable and unabsorbable four-strand core sutures. J Hand Surg Eur Vol. 2008 Aug. 33(4):412-7. [Medline].

  7. Potenza AD. Critical evaluation of flexor-tendon healing and adhesion formation within artificial digital sheaths. J Bone Joint Surg Am. 1963 Sep. 45:1217-33. [Medline].

  8. Matthews P, Richards H. Factors in the adherence of flexor tendon after repair: an experimental study in the rabbit. J Bone Joint Surg Br. 1976 May. 58(2):230-6. [Medline].

  9. Lindsay WK, Thomson HG. Digital flexor tendons: an experimental study. Part I. The significance of each component of the flexor mechanismhin tendon healing. Br J Plast Surg. 1960 Jan. 12:289-316. [Medline].

  10. Lindsay WK, Thomson HG, Walker FG. Digital flexor tendons: an experimental study. Part II. The significance of a gap occurring at the line of suture. Br J Plast Surg. 1960 Apr. 3:1-9. [Medline].

  11. Drapé JL, Silbermann-Hoffman O, Houvet P, Dubert T, Thivet A, Benmelha Z. Complications of flexor tendon repair in the hand: MR imaging assessment. Radiology. 1996 Jan. 198(1):219-24. [Medline].

  12. Corduff N, Jones R, Ball J. The role of ultrasound in the management of zone 1 flexor tendon injuries. J Hand Surg Br. 1994 Feb. 19(1):76-80. [Medline].

  13. McGeorge DD, McGeorge S. Diagnostic medical ultrasound in the management of hand injuries. J Hand Surg Br. 1990 May. 15(2):256-61. [Medline].

  14. Whitaker JH, Strickland JW, Ellis RK. The role of flexor tenolysis in the palm and digits. J Hand Surg Am. 1977 Nov. 2(6):462-70. [Medline].

  15. Walcher K, von Lüdinghausen M, Kuzmany J, Matzen KA, Küsswetter W. [Experimental "hormonal tenolysis" by cortisone therapy (author's transl)]. Arch Orthop Unfallchir. 1976 Feb 26. 84(1):1-12. [Medline].

  16. Wrenn RN, Goldner JL, Markee JL. An experimental study of the effect of cortisone on the healing process and tensile strength of tendons. J Bone Joint Surg Am. 1954 Jun. 36-A(3):588-601. [Medline].

  17. Hunter JM, Schneider LH, Dumont J, Erickson JC 3rd. A dynamic approach to problems of hand function using local anesthesia supplemented by intravenous fentanyl-droperidol. Clin Orthop Relat Res. 1974 Oct. (104):112-5. [Medline].

  18. Feldscher SB, Schneider LH. Flexor tenolysis. Hand Surg. 2002 Jul. 7(1):61-74. [Medline].

  19. Schneider LH. Tenolysis and capsulectomy after hand fractures. Clin Orthop Relat Res. 1996 Jun. (327):72-8. [Medline].

  20. Strickland JW. Flexor tenolysis. Hand Clin. 1985 Feb. 1(1):121-32. [Medline].

  21. Constantinescu MA, Greenwald DP, Amarante MT, Nishioka NS, May JW Jr. Effects of laser versus scalpel tenolysis in the rabbit flexor tendon. Plast Reconstr Surg. 1996 Mar. 97(3):595-601. [Medline].

  22. Foucher G, Lenoble E, Ben Youssef K, Sammut D. A post-operative regime after digital flexor tenolysis. A series of 72 patients. J Hand Surg Br. 1993 Feb. 18(1):35-40. [Medline].

  23. Wheeldon T. The use of cellophane as a permanent tendon sheeth. J Bone Joing Surg Am. 1939. 21:

  24. Karakurum G, Buyukbebeci O, Kalender M, Gulec A. Seprafilm interposition for preventing adhesion formation after tenolysis. An experimental study on the chicken flexor tendons. J Surg Res. 2003 Aug. 113(2):195-200. [Medline].

  25. Strickland JW. Flexor tendon injuries. Part 5. Flexor tenolysis, rehabilitation and results. Orthop Rev. 1987 Mar. 16(3):137-53. [Medline].

  26. Strickland JW. Flexor tendon injuries. Part 2. Flexor tendon repair. Orthop Rev. 1986 Nov. 15(11):701-21. [Medline].

  27. Wiig ME, Dahlin LB, Fridén J, Hagberg L, Larsen SE, Wiklund K, et al. PXL01 in sodium hyaluronate for improvement of hand recovery after flexor tendon repair surgery: randomized controlled trial. PLoS One. 2014. 9 (10):e110735. [Medline]. [Full Text].

  28. Branford OA, Klass BR, Grobbelaar AO, Rolfe KJ. The growth factors involved in flexor tendon repair and adhesion formation. J Hand Surg Eur Vol. 2014 Jan. 39 (1):60-70. [Medline]. [Full Text].

  29. Turner JB, Corazzini RL, Butler TJ, Garlick DS, Rinker BD. Evaluating adhesion reduction efficacy of type I/III collagen membrane and collagen-GAG resorbable matrix in primary flexor tendon repair in a chicken model. Hand (N Y). 2015 Sep. 10 (3):482-8. [Medline].

 
Previous
Next
 
Flexor tendons with attached vincula. FDS, flexor digitorum superficialis; FDP, flexor digitorum profundus.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.